ACADIA Pharmaceuticals Inc.ACADIA Pharmaceuticals Inc.ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals Inc.

No trades
See on Supercharts
Market capitalization
‪2.82 B‬USD
−0.38USD
‪−61.29 M‬USD
‪726.44 M‬USD
‪163.46 M‬
Beta (1Y)
1.85

About ACADIA Pharmaceuticals Inc.

CEO
Stephen R. Davis
Headquarters
San Diego
Website
Employees (FY)
598
Founded
1993
ISIN
US0042251084
FIGI
BBG000BHG9K0
ACADIA Pharmaceuticals, Inc. engages in the development and commercialization of medicines for central nervous system disorders. Its products include Nuplazid, which is used for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. The company was founded by Mark R. Brann on July 16, 1993 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of ACAD is 16.97 USD — it has decreased by 0.99% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange ACADIA Pharmaceuticals Inc. stocks are traded under the ticker ACAD.
ACADIA Pharmaceuticals Inc. is going to release the next earnings report on May 1, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for ACADIA Pharmaceuticals Inc. has a max estimate of 39.00 USD and a min estimate of 13.00 USD.
ACAD earnings for the last quarter are −0.40 USD whereas the estimation was −0.45 USD which accounts for 10.65% surprise. Estimated earnings for the next quarter are 0.29 USD. See more details about ACADIA Pharmaceuticals Inc. earnings.
ACADIA Pharmaceuticals Inc. revenue for the last quarter amounts to ‪211.70 M‬ USD despite the estimated figure of ‪192.32 M‬ USD. In the next quarter revenue is expected to reach ‪223.79 M‬ USD.
Yes, you can track ACADIA Pharmaceuticals Inc. financials in yearly and quarterly reports right on TradingView.
Like other stocks, ACAD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACADIA Pharmaceuticals Inc. stock right from TradingView charts — choose your broker and connect to your account.
ACAD reached its all-time high on Jul 7, 2020 with the price of 58.72 USD, and its all-time low was 0.65 USD and was reached on Nov 12, 2010.
See other stocks reaching their highest and lowest prices.
As of Apr 15, 2024, the company has 598.00 employees. See our rating of the largest employees — is ACADIA Pharmaceuticals Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACADIA Pharmaceuticals Inc. EBITDA is ‪−67.79 M‬ USD, and current EBITDA margin is −9.34%. See more stats in ACADIA Pharmaceuticals Inc. financial statements.